• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS MEDICAL SYSTEMS (CLEVELAND), INC. PINNACLE3 16.4 (ENG/FRA/DEU) SW; SYSTEM, PLANNING, RADIATION THERAPY TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS MEDICAL SYSTEMS (CLEVELAND), INC. PINNACLE3 16.4 (ENG/FRA/DEU) SW; SYSTEM, PLANNING, RADIATION THERAPY TREATMENT Back to Search Results
Model Number 16.4 PINNACLE3 ENG SW
Medical Device Problem Code Program or Algorithm Execution Failure (4036)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/17/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturing investigation currently underway.We have not completed our investigation of this event.We will file a follow-up emdr at the completion of the investigation.Internal cross reference: complaint (b)(4).Date of report (b)(6) 2022.
 
Event or Problem Description
Dose exported to 3rd party systems is different than what is in pinnacle 16.4.3 this behavior was identified at a customer site after they submitted a treatment plan for inclusion in a trial.The treatment plan was rejected by the trial because it did not meet dose requirements.Upon further investigation the user discovered that the dose information exported out of pinnacle did not match the dose in the plan in pinnacle.This issue is currently under investigation by the manufacturer.
 
Additional Manufacturer Narrative
Manufacturer¿s investigation has identified a specific coding issue that was introduced in the development phase of pinnacle software version 16.4.2 as the root cause of this issue.This coding issue has been corrected and this fix is being distributed to the customer via installation of a service pack, specifically in this case, 16.4.3 service pack 1.
 
Event or Problem Description
Dose exported to 3rd party systems is different than what is in pinnacle 16.4.3.This behavior was identified at a customer site after they submitted a treatment plan for inclusion in a trial.The treatment plan was rejected by the trial because it did not meet dose requirements.Upon further investigation the user discovered that the dose information exported out of pinnacle did not match the dose in the plan in pinnacle.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PINNACLE3 16.4 (ENG/FRA/DEU) SW
Common Device Name
SYSTEM, PLANNING, RADIATION THERAPY TREATMENT
Manufacturer (Section D)
PHILIPS MEDICAL SYSTEMS (CLEVELAND), INC.
100 park avenue, suite 300
orange village OH 44122
Manufacturer (Section G)
PHILIPS MEDICAL SYSTEMS (CLEVELAND), INC.
100 park avenue, suite 300
orange village OH 44122
Manufacturer Contact
marcus palmer
100 park avenue, suite 300
orange village, OH 44122
MDR Report Key14875409
Report Number3004022368-2022-00002
Device Sequence Number5073803
Product Code MUJ
UDI-Device Identifier00884838102965
UDI-Public00884838102965
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K170086
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number16.4 PINNACLE3 ENG SW
Device Catalogue Number870231
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/17/2022
Supplement Date Received by Manufacturer03/17/2022
Initial Report FDA Received Date06/30/2022
Supplement Report FDA Received Date09/16/2022
Was Device Evaluated by Manufacturer? (Y/N) No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-